Please select a Capability in order to start your service request.
On March 17, 2015, BD completed its acquisition of CareFusion. The combined company - the new BD - is comprised of more than 45,000 associates in 50 countries dedicated toHelping all people live healthy lives, with greater scale to focus on improving the quality and safety of care.
The new BD’s expanded offerings for medication management draw on more than a century of combined experience and span the continuum of care, from drug preparation in the pharmacy, to dispensing on the hospital floor, delivery to the patient, and subsequent monitoring. Now, CareFusion’s clinically proven product families - including some of the most widely recognized brand names in their categories - will join the BD family, including Pyxis® for medication and supply dispensing, Alaris® for infusion, AVEA® ventilators, Jaeger® for respiratory diagnostic instruments, AVAmax® and PleurX® for interventional procedures, V. Mueller® and Snowden-Pencer® surgical instruments, ChloraPrep® skin antiseptic, and AirLife® and Vital Signs® products for anesthesiology and respiratory care.
With the acquisition of CareFusion, BD is now stronger and more capable in our efforts to advance the quality, accessibility, safety and affordability of healthcare around the world through innovative offerings to help advance cellular research and applications; enhance the diagnosis of diseases and cancers; improve drug delivery and medication management; support infection prevention initiatives; enhance acute-care procedural effectiveness; improve anesthesiology and respiratory care; and aid in the management of diabetes.
Explore the new BD: